Braña Garcia, I., Shapiro, G. I., Trigo, J. M., Boni, V., Moreno, V., & Pistilli, B. (2022). Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: Results from a phase II basket study. Elsevier.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Braña Garcia, Irene, G. I. Shapiro, José Manuel Trigo, Valentina Boni, Victor Moreno, and Barbara Pistilli. Lurbinectedin, a Selective Inhibitor of Oncogenic Transcription, in Patients with Pretreated Germline BRCA1/2 Metastatic Breast Cancer: Results from a Phase II Basket Study. Elsevier, 2022.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Braña Garcia, Irene, et al. Lurbinectedin, a Selective Inhibitor of Oncogenic Transcription, in Patients with Pretreated Germline BRCA1/2 Metastatic Breast Cancer: Results from a Phase II Basket Study. Elsevier, 2022.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.